PTGFRN and cancer: In summary, this systematic meta-analysis suggests a crucial role for the rs743572 polymorphism in cancer pathogenesis, with particular prominence observed in bladder cancer, breast cancer, non-Hodgkin lymphoma, and hepatocellular cancer—a noteworthy observation supported by FPRP evaluation.